Adaptive Anti-Adhesive Barrier Membranes for Specialized Biomedical Applications

The inventive concept adapts the original anti-adhesive barrier membrane using alginate and hyaluronic acid for specialized biomedical applications, such as high-security medical facilities, disaster relief, extreme weather conditions, remote medical environments, and high-altitude medical environments.

The original patent disclosed a non-toxic, anti-adhesion hydrogel barrier membrane using alginate and hyaluronic acid for biomedical applications. However, the original patent did not address the specific needs of specialized biomedical applications, such as high-security medical facilities, disaster relief, extreme weather conditions, remote medical environments, and high-altitude medical environments. The new inventive concept addresses these limitations by adapting the original barrier membrane for these specific applications.

The new inventive concept comprises a system or method for preparing a non-toxic, anti-adhesion hydrogel barrier membrane using alginate and hyaluronic acid, adapted for use in high-security medical facilities, disaster relief, extreme weather conditions, remote medical environments, and high-altitude medical environments. The barrier membrane is designed to withstand specific operational environments, such as extreme temperatures and humidity, and to provide a non-cytotoxic and biocompatible surface for biomedical applications. The new claims provide a detailed description of the components and operation of the adapted barrier membrane, including the use of uncrosslinked hyaluronic acid, collagen, and negatively charged and hydrophilic surfaces.

The new claims provide a novel and non-obvious adaptation of the original barrier membrane for specialized biomedical applications. The inventive step lies in the specific design and operation of the adapted barrier membrane, which addresses the unique needs of high-security medical facilities, disaster relief, extreme weather conditions, remote medical environments, and high-altitude medical environments.

Alternative embodiments of the inventive concept could include the use of different biocompatible materials, such as chitosan or dextran, or the incorporation of additional components, such as antimicrobial agents or growth factors. Variations of the inventive concept could include the adaptation of the barrier membrane for use in veterinary medicine or in industrial applications.

The inventive concept has significant commercial potential in the biomedical industry, particularly in the areas of high-security medical facilities, disaster relief, extreme weather conditions, remote medical environments, and high-altitude medical environments. The target market includes medical device manufacturers, biomedical research institutions, and government agencies involved in disaster relief and emergency response.